Moreover, DSCAM-AS1 has been found to be transcriptionally regulated by ER and confer tamoxifen resistance in BC by interacting with hnRNPL, but the detailed mechanism remaining to be determined 63. Here, DSCAM-AS1 is linked to breast cancer.